AKQA
29.8.2017 08:02:08 CEST | Business Wire | Press release
DIS/PLAY is a digital agency that provides innovation, strategy, user experience, design, and technical development solutions to clients. Employing more than 100 people in Copenhagen and Aarhus, DIS/PLAY’s clients include ECCO, Amnesty International and Vestas.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170828005997/en/
DIS/PLAY’s Copenhagen and Aarhus studios will become part of AKQA, further building AKQA’s European presence and capabilities while providing DIS/PLAY with access to AKQA’s global network and resources.
Steffen Blauenfeldt Otkjær, DIS/PLAY’s CEO said: “AKQA leads globally in creativity and innovation, and DIS/PLAY’S strong technical capabilities make this relationship a natural fit. We are incredibly excited about the opportunities this partnership will create for our clients and team.”
Ajaz Ahmed, AKQA’s CEO said: “It has been a long held aspiration for AKQA to have a studio in Denmark, and thanks to our partnership with DIS/PLAY, that aspiration has become a reality. In the conversations that led to this partnership it quickly became apparent that DIS/PLAY’s ethos mirrors the values of AKQA.”
He added: “Denmark is one of the world’s most influential, beloved and respected nations, consistently taking the top spot on the United Nations World Happiness Report and first place in the Social Progress Index report. We look forward to learning from, and amplifying, this enlightened philosophy.”
Over the past two years, AKQA has added studios in many of the world’s cultural capitals including Sydney, Melbourne, Singapore, São Paulo, Milan, Venice and London. Combined with DIS/PLAY’s additional 110 employees, AKQA now has over 2,100 employees in 23 studios across the USA, Europe, Asia, and Australasia.
About AKQA
A recognised pioneer, AKQA is the global brand experience studio inspired by the imaginative application of art and science. AKQA has grown to become one of the world's most awarded digital agencies. AKQA is part of WPP, the world's largest communications services group. www.akqa.com
About DIS/PLAY
DIS/PLAY is one of the leading digital agencies in Denmark. Specialised in digital strategy, creativity and technology, DIS/PLAY employs 110 people in Copenhagen and Aarhus, who provide both Danish and global companies with quality work on a wide range of platforms - across all digital touchpoints. www.dis-play.dk
View source version on businesswire.com: http://www.businesswire.com/news/home/20170828005997/en/
Contact:
AKQA
Gyve Safavi, +44 79 0070 3311
gyve.safavi@akqa.com
or
DIS/PLAY
Jacob
Danstrup, +45 26 85 99 87
jda@dis-play.dk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom